2022
DOI: 10.1016/j.jddst.2021.103023
|View full text |Cite
|
Sign up to set email alerts
|

The protective effect of Boswellic acid and Ellagic acid loaded, colon targeted, and pH-sensitive N-succinyl chitosan in ulcerative colitis rat model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 47 publications
0
1
0
Order By: Relevance
“…In this context, EA-enriched pomegranate extract markedly decreased COX-2 and iNOS overexpression, reduced MAPKs phosphorylation, and prevented nuclear NF-κB translocation, thereby attenuated chronic colonic inflammation [84]. In an ulcerative colitis model induced by acetic acid in rats, EA administration decreased the protein levels of TNF-α, COX-2, and NF-κB, and thereby exerted protective effects on colonic inflammation [82]. In the acute DSS-induced mice colitis model, EA attenuated colitis severity slightly through the reduction of inflammatory mediators (IL-6, TNF-α, and IFN-γ) [83].…”
Section: Ellagic Acid (Ea)mentioning
confidence: 97%
“…In this context, EA-enriched pomegranate extract markedly decreased COX-2 and iNOS overexpression, reduced MAPKs phosphorylation, and prevented nuclear NF-κB translocation, thereby attenuated chronic colonic inflammation [84]. In an ulcerative colitis model induced by acetic acid in rats, EA administration decreased the protein levels of TNF-α, COX-2, and NF-κB, and thereby exerted protective effects on colonic inflammation [82]. In the acute DSS-induced mice colitis model, EA attenuated colitis severity slightly through the reduction of inflammatory mediators (IL-6, TNF-α, and IFN-γ) [83].…”
Section: Ellagic Acid (Ea)mentioning
confidence: 97%